CD8A and neoplasm: Evidence suggests that the frequency of neoepitope-specific CD8+ T cells in tumor-infiltrating lymphocytes (TILs), as well as the presentation of neoantigens by MHC I molecules and the load of neoantigens on the surface of tumor cells, has a positive relationship with prognosis in patients with solid tumors (20, 25, 26).